These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32399498)

  • 1. A pneumococcal controlled human infection model in Malawi: Transfer of an established pneumococcal carriage model from Liverpool, UK to Blantyre, Malawi - A feasibility study.
    Morton B; Burr S; Jambo K; Rylance J; Henrion MYR; Banda NP; Nsomba E; Kapumba B; Manda-Taylor L; Masesa C; Ferrreira D; Gordon SB;
    Wellcome Open Res; 2020; 5():25. PubMed ID: 32399498
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of pneumococcal conjugate vaccine-13 on nasal colonisation in a controlled human infection model of pneumococcal carriage in Malawi: a double-blinded randomised controlled trial protocol.
    Morton B; Jambo K; Chikaonda T; Rylance J; Henrion MYR; Banda NP; Nsomba E; Gondwe J; Ferreira D; Gordon SB;
    Wellcome Open Res; 2021; 6():240. PubMed ID: 36263101
    [No Abstract]   [Full Text] [Related]  

  • 3. A feasibility study of controlled human infection with Streptococcus pneumoniae in Malawi.
    Morton B; Burr S; Chikaonda T; Nsomba E; Manda-Taylor L; Henrion MYR; Banda NP; Rylance J; Ferreira DM; Jambo K; Gordon SB;
    EBioMedicine; 2021 Oct; 72():103579. PubMed ID: 34571365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental human pneumococcal carriage.
    Gritzfeld JF; Wright AD; Collins AM; Pennington SH; Wright AK; Kadioglu A; Ferreira DM; Gordon SB
    J Vis Exp; 2013 Feb; (72):. PubMed ID: 23439027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Density and Shorter Duration of Nasopharyngeal Carriage by Pneumococcal Serotype 1 (ST217) May Explain Its Increased Invasiveness over Other Serotypes.
    Bricio-Moreno L; Chaguza C; Yahya R; Shears RK; Cornick JE; Hokamp K; Yang M; Neill DR; French N; Hinton JCD; Everett DB; Kadioglu A
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293378
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.
    Lewnard JA; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2021 Oct; 73(7):e1423-e1433. PubMed ID: 33346348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pragmatic health centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+0 to 2+1 in a high pneumococcal carriage and disease burden setting in Malawi: a study protocol.
    Swarthout TD; Ibarz-Pavon A; Kawalazira G; Sinjani G; Chirombo J; Gori A; Chalusa P; Bonomali F; Nyirenda R; Bulla E; Brown C; Msefula J; Banda M; Kachala J; Mwansambo C; Henrion MY; Gordon SB; French N; Heyderman RS
    BMJ Open; 2021 Jun; 11(6):e050312. PubMed ID: 34140345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study.
    Shrestha S; Gurung M; Amatya P; Bijukchhe S; Bose AS; Carter MJ; Gautam MC; Gurung S; Hinds J; Kandasamy R; Kelly S; Khadka B; Maskey P; Mujadidi YF; O'Reilly PJ; Pokhrel B; Pradhan R; Shah GP; Shrestha S; Wahl B; O'Brien KL; Knoll MD; Murdoch DR; Kelly DF; Thorson S; Voysey M; Pollard AJ;
    Lancet Glob Health; 2022 Oct; 10(10):e1494-e1504. PubMed ID: 36113533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children.
    Kamng'ona AW; Hinds J; Bar-Zeev N; Gould KA; Chaguza C; Msefula C; Cornick JE; Kulohoma BW; Gray K; Bentley SD; French N; Heyderman RS; Everett DB
    BMC Infect Dis; 2015 Jun; 15():234. PubMed ID: 26088623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi.
    Kirolos A; Swarthout TD; Mataya AA; Bonomali F; Brown C; Msefula J; Bar-Zeev N; Iroh Tam PY; Alaerts M; Bilima S; Heyderman RS; French N
    BMC Infect Dis; 2023 Jan; 23(1):56. PubMed ID: 36703117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2).
    Liatsikos K; Hyder-Wright A; Pojar S; Chen T; Wang D; Davies K; Myerscough C; Reine J; Robinson RE; Urban B; Mitsi E; Solorzano C; Gordon SB; Quinn A; Pan K; Anderson AS; Theilacker C; Begier E; Gessner BD; Collins A; Ferreira DM;
    BMJ Open; 2022 Jul; 12(7):e062109. PubMed ID: 35798520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
    Richards L; Ferreira DM; Miyaji EN; Andrew PW; Kadioglu A
    Immunobiology; 2010 Apr; 215(4):251-63. PubMed ID: 20071053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study.
    Swarthout TD; Henrion MYR; Thindwa D; Meiring JE; Mbewe M; Kalizang'Oma A; Brown C; Msefula J; Moyo B; Mataya AA; Barnaba S; Pearce E; Gordon M; Goldblatt D; French N; Heyderman RS
    Lancet Infect Dis; 2022 Dec; 22(12):1737-1747. PubMed ID: 36029796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Heinsbroek E; Tafatatha T; Phiri A; Swarthout TD; Alaerts M; Crampin AC; Chisambo C; Mwiba O; Read JM; French N
    Vaccine; 2018 Nov; 36(48):7369-7376. PubMed ID: 30352744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Pneumococcal Serotyping of Nasopharyngeal-Carriage Isolates by Latex Agglutination, Whole-Genome Sequencing (PneumoCaT), and DNA Microarray in a High-Pneumococcal-Carriage-Prevalence Population in Malawi.
    Swarthout TD; Gori A; Bar-Zeev N; Kamng'ona AW; Mwalukomo TS; Bonomali F; Nyirenda R; Brown C; Msefula J; Everett D; Mwansambo C; Gould K; Hinds J; Heyderman RS; French N
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study.
    Lourenço J; Obolski U; Swarthout TD; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; French N; Heyderman RS
    BMC Med; 2019 Dec; 17(1):219. PubMed ID: 31801542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.
    Hales C; Jochems SP; Robinson R; Solórzano C; Carniel B; Pojar S; Reiné J; German EL; Nikolaou E; Mitsi E; Hyder-Wright AD; Hill H; Adler H; Connor V; Zaidi S; Lowe C; Fan X; Wang D; Gordon SB; Rylance J; Ferreira DM
    Vaccine; 2020 Feb; 38(10):2298-2306. PubMed ID: 32035708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
    Thindwa D; Mwalukomo TS; Msefula J; Jambo KC; Brown C; Kamng'ona A; Mwansambo C; Ojal J; Flasche S; French N; Heyderman RS; Swarthout TD
    AIDS; 2022 Nov; 36(14):2045-2055. PubMed ID: 35983828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.
    Hammitt LL; Akech DO; Morpeth SC; Karani A; Kihuha N; Nyongesa S; Bwanaali T; Mumbo E; Kamau T; Sharif SK; Scott JA
    Lancet Glob Health; 2014 Jul; 2(7):e397-405. PubMed ID: 25103393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.